Ledger.Open graph →

SEC Form D · filed December 22, 2015

Erytech Pharma S.A

Offering

$4.0M

Sold

$4.0M

Exemption

Rule 506(b)

Industry

Biotechnology

Location

LYON, I0

Type

—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (18)

Gil Beyen · LYON, I0Exec · Director Martine George · SKILLMAN, NJDirector Sven Andreasson · LYON, I0Director Hilde Windels · MOORTSELE, C9Director Yann Godfrin · LYON, I0Exec · Director Eric Soyer · LYON, I0Exec Philippe Archinard · TASSIN-LA-DEMI-LUNE, I0Director Luc Dochez · Leiden, P7Director Jerome Bailly · CHASSIEU, I0Exec Gil Beyen · LYON, I0Exec · Director Martine George · SKILLMAN, NJDirector Sven Andreasson · LYON, I0Director Hilde Windels · MOORTSELE, C9Director Yann Godfrin · LYON, I0Exec · Director Eric Soyer · LYON, I0Exec Philippe Archinard · TASSIN-LA-DEMI-LUNE, I0Director Luc Dochez · Leiden, P7Director Jerome Bailly · CHASSIEU, I0Exec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗